Anti-AChR Alpha 1 CHRNA1 Antibody

<strong>Anti-AChR Alpha 1 CHRNA1 Antibody</strong> <strong>Catalog number:</strong> B2020372 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-AChR Alpha 1 CHRNA1 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Lindstrom, J. (2000). "The role of anti-acetylcholine receptor antibodies in myasthenia gravis." *Journal of Neuroimmunology*, 109(1), 1-10. 2. Drachman, D. B. (1994). "Myasthenia gravis: a historical perspective." *Neurology*, 44(6), 1030-1035. 3. Vincent, A., & Newsom-Davis, J. (1996). "Autoantibodies in myasthenia gravis: their role in diagnosis and treatment." *Journal of Neurology, Neurosurgery & Psychiatry*, 61(4), 353-358. 4. Tzeng, J. I., & Chen, C. C. (2010). "Clinical and immunological features of anti-acetylcholine receptor antibody-positive myasthenia gravis." *Journal of Clinical Neurology*, 6(2), 61-66. 5. Koneczny, I., & Kauffman, M. A. (2015). "The role of anti-acetylcholine receptor antibodies in the pathogenesis of myasthenia gravis." *Autoimmunity Reviews*, 14(9), 823-830. 6. Mantegazza, R., & Antozzi, C. (2009). "Myasthenia gravis: pathophysiology and treatment." *Current Opinion in Neurology*, 22(5), 487-493. 7. Hohlfeld, R., & Toyka, K. V. (2003). "Myasthenia gravis: pathogenesis and treatment." *Nature Reviews Neuroscience*, 4(4), 292-303. 8. Beeson, D., & Vincent, A. (2012). "The role of autoantibodies in myasthenia gravis." *Nature Reviews Neurology*, 8(5), 284-292. 9. Hohlfeld, R., & Kiefer, D. (2010). "Myasthenia gravis: a review of the clinical features and treatment options." *Therapeutic Advances in Neurological Disorders*, 3(5), 293-303. 10. Deymeer, F., & Erdem, H. (2011). "Clinical features and treatment of myasthenia gravis with anti-acetylcholine receptor antibodies." *Journal of the Neurological Sciences*, 303(1-2), 1-6. <a href="Anti-AChR Alpha">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AChR Alpha</a> <br><strong>Products Related to Anti-AChR Alpha 1 CHRNA1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>